Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
L.P. Robertson, P. Hickling.
Treatment of recalcitrant orogenital ulceration of Behcet's syndrome with infliximab.
Rheumatology, 40 (2001), pp. 473-474
[2.]
P.P. Sfikakis, P.G. Theodossiadis, C.G. Katsiari, P. Kaklamanis, N.N. Markomi-chelakis.
Effect of infliximab on sight-threatening panuveitis in Behçet's disease.
Lancet, 358 (2001), pp. 295-296
[3.]
S. Muñoz Fernández, V. Hidalgo, J. Fernández Melón, A. Schlincker, E. Martín Mola.
Effect of infliximab on threatening panuveitis in Behçet's disease.
Lancet, 358 (2001), pp. 1644
[4.]
M.T. Kram, L.D. May, S. Goodman, S. Molinas.
Behcet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case.
Dis Colon Rectum, 46 (2003), pp. 118-121
[5.]
S.P.L. Travis, M. Czajkowski, D.P.B. McGovern, R.G.P. Watson, A.L. Bell.
Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody.
Gut, 49 (2001), pp. 725-728
[6.]
M. Melikoglu, I. Fresko, C. Mat, Y. Ozyazgan, F. Gogus, S. Yurdakul, et al.
Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
J Rheumatol, 32 (2005), pp. 98-105
[7.]
G. Licata, A. Pinto, A. Tuttolomondo, A. Banco, F. Ciccia, A. Ferrante, et al.
Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.
Ann Rheum Dis, 62 (2003), pp. 280-281
[8.]
H. Sarwar, H. McGrath Jr, L.R. Espinoza.
Successful treatment of longstanding neuro-Behçet's disease with infliximab.
J Rheumatol, 32 (2005), pp. 181-183
[9.]
F.J. García Hernández, C. Ocaña Medina, L. Mateos Romero, J. Sánchez Román, D. García Solís, J. Ruiz Franco-Baux, et al.
Utilidad de la SPECT cerebral con HMPAO-99mTc y de los test psicométricos en el diagnóstico de la afección neurológica de la enfermedad de Behçet.
Med Clin (Barc), 119 (2002), pp. 447-450
Copyright © 2007. Elsevier España S.L Barcelona
